<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34894954</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1475-6374</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of enzyme inhibition and medicinal chemistry</Title>
          <ISOAbbreviation>J Enzyme Inhib Med Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dithiocarbamates effectively inhibit the α-carbonic anhydrase from <i>Neisseria gonorrhoeae</i>.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>8</EndPage>
          <MedlinePgn>1-8</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/14756366.2021.1988945</ELocationID>
        <Abstract>
          <AbstractText>Recently, inorganic anions and sulphonamides, two of the main classes of zinc-binding carbonic anhydrase inhibitors (CAIs), were investigated for inhibition of the α-class carbonic anhydrase (CA, EC 4.2.1.1) from <i>Neisseria gonorrhoeae</i>, NgCA. As an extension to our previous studies, we report that dithiocarbamates (DTCs) derived from primary or secondary amines constitute a class of efficient inhibitors of NgCA. K<sub>I</sub>s ranging between 83.7 and 827 nM were measured for a series of 31 DTCs that incorporated various aliphatic, aromatic, and heterocyclic scaffolds. A subset of DTCs were selected for antimicrobial testing against <i>N. gonorrhoeae</i>, and three molecules displayed minimum inhibitory concentration (MIC) values less than or equal to 8 µg/mL. As NgCA was recently validated as an antibacterial drug target, the DTCs may lead to development of novel antigonococcal agents.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Giovannuzzi</LastName>
            <ForeName>Simone</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abutaleb</LastName>
            <ForeName>Nader S</ForeName>
            <Initials>NS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hewitt</LastName>
            <ForeName>Chad S</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carta</LastName>
            <ForeName>Fabrizio</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nocentini</LastName>
            <ForeName>Alessio</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-3342-702X</Identifier>
            <AffiliationInfo>
              <Affiliation>Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seleem</LastName>
            <ForeName>Mohamed N</ForeName>
            <Initials>MN</Initials>
            <Identifier Source="ORCID">0000-0003-0939-0458</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Emerging Zoonotic and Arthropod-borne Pathogens, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flaherty</LastName>
            <ForeName>Daniel P</ForeName>
            <Initials>DP</Initials>
            <Identifier Source="ORCID">0000-0002-8305-0606</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Purdue Institute for Drug Discovery, West Lafayette, IN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Purdue Institute of Inflammation, Immunology and Infectious Disease, West Lafayette, IN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Supuran</LastName>
            <ForeName>Claudiu T</ForeName>
            <Initials>CT</Initials>
            <Identifier Source="ORCID">0000-0003-4262-0323</Identifier>
            <AffiliationInfo>
              <Affiliation>Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 AI148523</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Enzyme Inhib Med Chem</MedlineTA>
        <NlmUniqueID>101150203</NlmUniqueID>
        <ISSNLinking>1475-6366</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002257">Carbonic Anhydrase Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013859">Thiocarbamates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 4.2.1.1</RegistryNumber>
          <NameOfSubstance UI="D002256">Carbonic Anhydrases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002257" MajorTopicYN="N">Carbonic Anhydrase Inhibitors</DescriptorName>
          <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002256" MajorTopicYN="N">Carbonic Anhydrases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013859" MajorTopicYN="N">Thiocarbamates</DescriptorName>
          <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Carbonic anhydrase</Keyword>
        <Keyword MajorTopicYN="N">Neisseria gonorrhoeae</Keyword>
        <Keyword MajorTopicYN="N">antibacterials</Keyword>
        <Keyword MajorTopicYN="N">dithiocarbamate</Keyword>
        <Keyword MajorTopicYN="N">inhibitor</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no relevant affiliations of financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. CT Supuran is Editor-in-Chief of the Journal of Enzyme Inhibition and Medicinal Chemistry. He was not involved in the assessment, peer review, or decision-making process of this paper. The authors have no relevant affiliations of financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>13</Day>
          <Hour>11</Hour>
          <Minute>25</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34894954</ArticleId>
        <ArticleId IdType="pmc">PMC8667944</ArticleId>
        <ArticleId IdType="doi">10.1080/14756366.2021.1988945</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>(a) Supuran CT.
Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?
Front Pharmacol
2011;2:34. (b) Flaherty DP, Seleem MN, Supuran CT.. 
Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. Future Med Chem
2021;13: 1619–22.</Citation>
        </Reference>
        <Reference>
          <Citation>(a) Supuran CT, Capasso C.. 
Antibacterial carbonic anhydrase inhibitors: an update on the recent literature. Expert Opin Ther Pat
2020;30:963–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32806966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Campestre C, De Luca V, Carradori S, et al. . 
Carbonic anhydrases: new perspectives on protein functional role and inhibition in Helicobacter pylori. Front Microbiol
2021;12:629163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32806966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Capasso C, Supuran CT.. 
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
J Enzyme Inhib Med Chem
2015;30:325–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32806966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(d) Supuran CT, Capasso C.. 
Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat
2018; 28:745–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32806966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Smith KS, Jakubzick C, Whittam TS, Ferry JG.. 
Carbonic anhydrase is an ancient enzyme widespread in prokaryotes. Proc Natl Acad Sci USA
1999;96:15184–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC24794</ArticleId>
            <ArticleId IdType="pubmed">10611359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b). Abuaita BH, Withey JH.. 
Bicarbonate induces Vibrio cholerae virulence gene expression by enhancing ToxT activity. Infect Immun
2009;77:4111–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC24794</ArticleId>
            <ArticleId IdType="pubmed">10611359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Merlin C, Masters M, McAteer S, Coulson A.. 
Why is carbonic anhydrase essential to Escherichia coli?
J Bacteriol
2003;185:6415–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC24794</ArticleId>
            <ArticleId IdType="pubmed">10611359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(d) Del Prete S, Nocentini A, Supuran CT, Capasso C.. 
Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem
2020;35:1060–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC24794</ArticleId>
            <ArticleId IdType="pubmed">10611359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Kaur J, Cao X, Abutaleb NS, et al. . 
Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant enterococcus. J Med Chem
2020;63:9540–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317130</ArticleId>
            <ArticleId IdType="pubmed">32787141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Abutaleb NS, Elkashif A, Flaherty DP, Seleem MN.. 
In vivo antibacterial activity of acetazolamide. Antimicrob Agents Chemother
2021;65:e01715–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317130</ArticleId>
            <ArticleId IdType="pubmed">32787141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Abutaleb NS, Elhassanny AEM, Flaherty DP, Seleem MN.. 
In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. PeerJ
2021;9:e11059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317130</ArticleId>
            <ArticleId IdType="pubmed">32787141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Hewitt CS, Abutaleb NS, Elhassanny AEM, et al. . 
Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae. ACS Infect Dis
2021;7:1969–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317129</ArticleId>
            <ArticleId IdType="pubmed">33765392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Nocentini A, Hewitt CS, Mastrolorenzo MD, et al. . 
Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem
2021;36:1061–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8317129</ArticleId>
            <ArticleId IdType="pubmed">33765392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Golparian D, Sánchez-Busó L, Cole M, Unemo M.. 
Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions. J Antimicrob Chemother
2021;76:940–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33411920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Turner JM, Connolly KL, Aberman KE, et al. . 
Molecular features of cephalosporins important for activity against antimicrobial-resistant Neisseria gonorrhoeae. ACS Infect Dis
2021;7:293–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33411920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Yahara K, Ma KC, Mortimer TD, et al. . 
Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae. Genome Med
2021;13:51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8008663</ArticleId>
            <ArticleId IdType="pubmed">33785063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Jacobsson S, Cole MJ, Spiteri G, on behalf of The Euro-GASP Network, et al.. 
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients’ gender, sexual orientation and anatomical site of infection, 2009–2016. BMC Infect Dis
2021;21:273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8008663</ArticleId>
            <ArticleId IdType="pubmed">33785063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Aho EL, Ogle JM, Finck AM.. 
The human microbiome as a focus of antibiotic discovery: Neisseria mucosa displays activity against Neisseria gonorrhoeae. Front Microbiol
2020;11:577762.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8008663</ArticleId>
            <ArticleId IdType="pubmed">33785063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Murray AB, Aggarwal M, Pinard M, et al. . 
Structural mapping of anion inhibitors to β-carbonic anhydrase psCA3 from Pseudomonas aeruginosa. ChemMedChem
2018;13:2024–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30088334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Pinard MA, Lotlikar SR, Boone CD, et al. . 
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa. Bioorg Med Chem
2015;23:4831–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30088334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Matsumoto Y, Miyake K, Ozawa K, et al. . 
Bicarbonate and unsaturated fatty acids enhance capsular polysaccharide synthesis gene expression in oral streptococci, Streptococcus anginosus. J Biosci Bioeng
2019;128:511–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31130336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Capasso C, Supuran CT.. 
An overview of the carbonic anhydrases from two pathogens of the oral cavity: Streptococcus mutans and Porphyromonas gingivalis. Curr Top Med Chem
2016;16:2359–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31130336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Dedeoglu N, De Luca V, Isik S, et al. . 
Cloning, characterization and anion inhibition study of a β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans. Bioorg Med Chem
2015;23:2995–3001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31130336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(d) Burghout P, Vullo D, Scozzafava A, et al. . 
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives?
Bioorg Med Chem
2011;19:243–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31130336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Supuran CT.
Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov
2020;15:671–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32208982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Supuran CT.
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov
2008; 7:168–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32208982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Mishra CB, Tiwari M, Supuran CT.. 
Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?
Med Res Rev
2020;40:2485–565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32208982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) De Simone G, Supuran CT.. 
(In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem
2012; 111:117–29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22192857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Ozensoy Guler O, Capasso C, Supuran CT.. 
A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization. J Enzym Inhib Med Chem
2016;31:689–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22192857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Nocentini A, Angeli A, Carta F, et al. . 
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem. 2021;36:561–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22192857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(d) Supuran CT.
Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem
2012;27:759–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22192857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(e) Supuran CT.
How many carbonic anhydrase inhibition mechanisms exist?
J Enzyme Inhib Med Chem
2016;31:345–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22192857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalifah RG.
The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem
1971;246:2561–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4994926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Petreni A, De Luca V, Scaloni A, et al. . 
Anion inhibition studies of the Zn(II)-bound ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem
2021; 36:372–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7782983</ArticleId>
            <ArticleId IdType="pubmed">33390061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) De Luca V, Petreni A, Nocentini A, et al. . 
Effect of sulfonamides and their structurally related derivatives on the activity of ι -carbonic anhydrase from Burkholderia territorii. Int J Mol Sci
2021;22:571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7782983</ArticleId>
            <ArticleId IdType="pubmed">33390061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Angeli A, Pinteala M, Maier SS, et al. . 
Inhibition of α-, β-, γ-, δ-, ζ- and η-class carbonic anhydrases from bacteria, fungi, algae, diatoms and protozoans with famotidine. J Enzyme Inhib Med Chem
2019;34:644–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6366436</ArticleId>
            <ArticleId IdType="pubmed">30727781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Urbański LJ, Di Fiore A, Azizi L, et al.  S. Biochemical and structural characterisation of a protozoan beta-carbonic anhydrase from Trichomonas vaginalis. J Enzyme Inhib Med Chem
2020;35:1292–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6366436</ArticleId>
            <ArticleId IdType="pubmed">30727781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Forkman A, Laurell AB.. 
The effect of carbonic anhydrase inhibitor on the growth of Neisseriae. Acta Pathol Microbiol Scand
1965;65:450–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4957132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Nafi BM, Miles RJ, Butler LO, et al. . 
Expression of carbonic anhydrase in neisseriae and other heterotrophic bacteria. J Med Microbiol
1990;32:1–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4957132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Chirică LC, Elleby B, Jonsson BH, Lindskog S.. 
The complete sequence, expression in Escherichia coli, purification and some properties of carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem
1997;244:755–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9108244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Elleby B, Chirica LC, Tu C, et al. . 
Characterization of carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem
2001;268:1613–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9108244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Temperini C, Scozzafava A, Supuran CT.. 
Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme. Bioorg Med Chem Lett
2010;20:474–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20005709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Innocenti A, Scozzafava A, Supuran CT.. 
Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate. Bioorg Med Chem Lett
2010;20:1548–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20005709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Carta F, Aggarwal M, Maresca A, et al. . 
Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun
2012; 48:1868–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22218610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Carta F, Aggarwal M, Maresca A, et al. . 
Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. J Med Chem
2012;55:1721–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22218610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Syrjänen L, Tolvanen ME, Hilvo M, et al. . 
Characterization, bioinformatic analysis and dithiocarbamate inhibition studies of two new α-carbonic anhydrases, CAH1 and CAH2, from the fruit fly Drosophila melanogaster. Bioorg Med Chem
2013;21:1516–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22218610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Alhashimi M, Mayhoub A, Seleem MN.. 
Repurposing salicylamide for combating multidrug-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother
2019;63:e01225–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6879211</ArticleId>
            <ArticleId IdType="pubmed">31570391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Seong YJ, Alhashimi M, Mayhoub A, et al. . 
Repurposing fenamic acid drugs to combat multidrug-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother
2020;64:e02206–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6879211</ArticleId>
            <ArticleId IdType="pubmed">31570391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(c) Elkashif A, Seleem MN.. 
Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae. Sci Rep
2020;10:1–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6879211</ArticleId>
            <ArticleId IdType="pubmed">31570391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Vullo D, Durante M, Di Leva FS, et al. . 
Monothiocarbamates strongly inhibit carbonic anhydrases in vitro and possess intraocular pressure lowering activity in an animal model of glaucoma. J Med Chem
2016; 59:5857–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27253845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Carta F, Akdemir A, Scozzafava A, et al. . 
Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo. J Med Chem
2013; 56:4691–700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27253845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Sanders E, Maren TH.. 
Inhibition of carbonic anhydrase in Neisseria: effects on enzyme activity and growth. Mol Pharmacol
1967;3:204–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4962249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Nafi BM, Miles RJ, Butler LO, et al. . 
Expression of carbonic anhydrase in neisseriae and other heterotrophic bacteria. J Med Microbiol
1990;32:1–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4962249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richter MF, Drown BS, Riley AP, et al. . 
Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature
2017;545:299–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5737020</ArticleId>
            <ArticleId IdType="pubmed">28489819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(a) Urbanski LJ, Bua S, Angeli A, et al. . 
Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase. J Enzyme Inhib Med Chem
2020;35:1834–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7534311</ArticleId>
            <ArticleId IdType="pubmed">32972256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(b) Fan SH, Ebner P, Reichert S, et al. . 
MpsAB is important for Staphylococcus aureus virulence and growth at atmospheric CO2 levels. Nat Commun
2019;10:3627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7534311</ArticleId>
            <ArticleId IdType="pubmed">32972256</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
